1. Academic Validation
  2. Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells

Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells

  • Bioorg Med Chem Lett. 2010 May 1;20(9):2994-7. doi: 10.1016/j.bmcl.2010.02.062.
Souichi Nakashima 1 Hisashi Matsuda Ai Kurume Yoshimi Oda Seikou Nakamura Masayuki Yamashita Masayuki Yoshikawa
Affiliations

Affiliation

  • 1 Department of Pharmacognosy, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607-8412, Japan.
Abstract

Cucurbitane-type Triterpenes, cucurbitacins B and E, were reported to exhibit cytotoxic effects in several cell lines mediated by JAK/STAT3 signaling. However, neither compound inhibited phosphorylation of STAT3 in human leukemia (U937) cells at low concentrations. We therefore synthesized a biotin-linked cucurbitacin E to isolate target proteins based on affinity for the molecule. As a result, cofilin, which regulates the depolymerization of actin, was isolated and suggested to be a target. Cucurbitacins E and I inhibited the phosphorylation of cofilin in a concentration-dependent manner, and their effective concentrations having the same range as the concentrations at which they had cytotoxic effects in U937 cells. In addition, the fibrous-/globular-actin ratio was decreased after treatment with cucurbitacin E in HT1080 cells. These findings suggested that the inhibition of cofilin's phosphorylation increased the severing activity of cofilin, and then the depolymerization of actin was enhanced after treatment with cucurbitacin E at lower concentrations.

Figures